Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
Worth Seeing!
Top Stocks to Buy: Get 13 Picks That We Think Will Soar
Claim Your Stock Picks
Claim Your Stock Picks
BSE: 0 | NSE: ARISTO | Pesticides & Agrochemicals | Small Cap
Past 10 year's financial track record analysis by Moneyworks4me indicates that Aristo Bio-Tech and Lifescience Ltd is a average quality company.
The key valuation ratios of Aristo Bio-Tech and Lifescience Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aristo Bio-Tech and Lifescience Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 0% | 0% | 0% | 17.3% | 9.8% | 7.5% | 7.7% | 11.6% | - |
| Value Creation Index ⓘ | NA | NA | NA | NA | NA | 0.2 | -0.3 | -0.5 | -0.5 | -0.2 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 202 | 201 | 167 | 166 | 218 | 218 |
| Sales YoY Gr. | - | NA | NA | NA | NA | NA | -0.2% | -16.9% | -0.9% | 31.4% | - |
| Adj EPS ⓘ | 0 | 0 | 0 | 0 | 0 | 5.8 | 2 | 1.9 | 2.5 | 5.1 | 5.2 |
| YoY Gr. | - | NA | NA | NA | NA | NA | -64.9% | -7.4% | 35.3% | 100.8% | - |
| BVPS (₹) ⓘ | 0 | 0 | 0 | 0 | 0 | 22.6 | 24.6 | 26.8 | 29.8 | 44.3 | 44.3 |
| Adj Net Profit ⓘ | 0 | 0 | 0 | 0 | 0 | 2.9 | 1 | 0.9 | 1.3 | 3.5 | 4 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 8.2 | 1.4 | 2.3 | 6.8 | -2.8 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 1.8 | 14 | 9.7 | 3.8 | -8.1 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | 2.7% | 31.4% | ||||
| Adj EPS ⓘ | NA | NA | 36% | 100.8% | ||||
| BVPSⓘ | NA | NA | 21.6% | 48.9% | ||||
| Share Price | - | - | - | 45.1% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 0 | 0 | 0 | 25.5 | 8.5 | 7.3 | 9 | 15.4 | 11.8 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 3.4 | 2.2 | 2.6 | 3.1 | 4 | NAN |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 1.4 | 0.5 | 0.6 | 0.8 | 1.6 | 1.6 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 1.3 | 1.6 | 1.7 | 1.7 | 0.8 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 122 | 135 | 144 | 120 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 41 | 51 | 42 | 0 |
Return on Equity has increased versus last 3 years average to 11.80%
Net Profit is growing at healthy rate in last 3 years 35.99%
Debt to equity has declined versus last 3 years average to 0.75
Sales growth has been subdued in last 3 years 2.66%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 5.2 | - |
| TTM Sales (₹ Cr.) | 218 | - |
| BVPS (₹.) ⓘ | 44.3 | - |
| Reserves (₹ Cr.) ⓘ | 23 | - |
| P/BV ⓘ | 1.87 | - |
| PE ⓘ | 15.87 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 0.00 / 0.00 |
| All Time Low / High (₹) | - / - |
| Market Cap (₹ Cr.) | 56.5 |
| Equity (₹ Cr.) | 6.8 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 35.9 |
| Pledged * | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|
| Sales | 201.67 | 201.23 | 167.22 | 165.76 | 217.75 |
| Operating Expenses ⓘ | 194.85 | 196.72 | 162.87 | 160.59 | 209.05 |
| Manufacturing Costs | 1.65 | 1.78 | 3.45 | 5.28 | 3.95 |
| Material Costs | 184.16 | 187.54 | 150.03 | 147.06 | 195.77 |
| Employee Cost | 3.93 | 2.72 | 2.52 | 4.29 | 4.74 |
| Other Costs ⓘ | 5.11 | 4.68 | 6.87 | 3.95 | 4.60 |
| Operating Profit ⓘ | 6.82 | 4.51 | 4.34 | 5.17 | 8.70 |
| Operating Profit Margin (%) | 3.4% | 2.2% | 2.6% | 3.1% | 4.0% |
| Other Income ⓘ | 0.11 | 0.01 | 0.22 | 0.27 | 0.33 |
| Interest ⓘ | 2.25 | 2.60 | 2.31 | 2.36 | 2.75 |
| Depreciation ⓘ | 0.51 | 0.52 | 0.75 | 1.10 | 1.54 |
| Exceptional Items ⓘ | -0.07 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 4.10 | 1.40 | 1.50 | 1.98 | 4.74 |
| Tax ⓘ | 1.27 | 0.39 | 0.42 | 0.55 | 1.18 |
| Profit After Tax | 2.83 | 1.01 | 1.08 | 1.43 | 3.56 |
| PAT Margin (%) | 1.4% | 0.5% | 0.6% | 0.9% | 1.6% |
| Adjusted EPS (₹) | 5.7 | 2.0 | 2.2 | 2.9 | 5.2 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 5% |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 11.30 | 12.31 | 13.38 | 14.87 | 30.16 | |||||
| Share Capital ⓘ | 5 | 5 | 5 | 5 | 6.81 | |||||
| Reserves ⓘ | 6.30 | 7.31 | 8.39 | 9.87 | 23.35 | |||||
| Minority Interest | 0 | 0 | 0 | 0 | 0 | |||||
| Debt | 13.29 | 18.27 | 21.36 | 23.76 | 20.11 | |||||
| Long Term Debt | 7.20 | 10.67 | 12.06 | 11.09 | 10.17 | |||||
| Short Term Debt | 6.09 | 7.60 | 9.30 | 12.67 | 9.94 | |||||
| Trade Payables | 62.57 | 37.81 | 38.35 | 35.21 | 45.39 | |||||
| Others Liabilities ⓘ | 3.41 | 19.39 | 8.32 | 3.17 | 4.16 | |||||
| Total Liabilities ⓘ | 90.58 | 87.78 | 81.42 | 77 | 99.82 | |||||
Fixed Assets | ||||||||||
| Gross Block | 11.21 | 12.08 | 16.88 | 19.94 | 22.74 | |||||
| Accumulated Depreciation | 3.30 | 3.82 | 4.57 | 5.58 | 7.12 | |||||
| Net Fixed Assetsⓘ | 7.91 | 8.26 | 12.31 | 14.36 | 15.62 | |||||
| CWIP ⓘ | 1.48 | 2.82 | 0 | 0.10 | 1.10 | |||||
| Investmentsⓘ | 0 | 0 | 0 | 0 | 0 | |||||
| Inventories | 32.99 | 24.32 | 31.95 | 24.36 | 30.78 | |||||
| Trade Receivables | 42.26 | 48.31 | 32.77 | 33.20 | 44.57 | |||||
| Cash Equivalents | 0.44 | 0.53 | 0.11 | 0.42 | 1.85 | |||||
| Others Assetsⓘ | 5.49 | 3.55 | 4.28 | 4.56 | 5.90 | |||||
| Total Assets ⓘ | 90.58 | 87.78 | 81.42 | 77 | 99.82 | |||||
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 8.15 | 1.41 | 2.28 | 6.78 | -2.78 |
| PBT ⓘ | 4.17 | 1.40 | 1.50 | 1.98 | 4.74 |
| Adjustment ⓘ | 2.56 | 3.49 | 3.22 | 3.44 | 4.23 |
| Changes in Working Capital ⓘ | 2.66 | -3.07 | -2.09 | 1.71 | -10.58 |
| Tax Paid ⓘ | -1.24 | -0.41 | -0.34 | -0.35 | -1.26 |
| Cash Flow From Investing Activity ⓘ | -2.44 | -2.19 | -1.98 | -3.16 | -3.75 |
| Capex | -0.58 | -0.87 | -1.44 | -3.15 | -2.53 |
| Net Investments | 0 | 0 | 0 | 0 | -0.01 |
| Others ⓘ | -1.87 | -1.32 | -0.54 | -0.01 | -1.21 |
| Cash Flow From Financing Activityⓘ | -5.77 | 0.87 | -0.72 | -3.31 | 7.97 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 11.73 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | -0.97 | -0.93 |
| Interest Paid ⓘ | -2.25 | -2.60 | -2.11 | -2.35 | -2.51 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | -3.52 | 3.47 | 1.39 | 0.01 | -0.33 |
| Net Cash Flow ⓘ | -0.06 | 0.09 | -0.41 | 0.30 | 1.44 |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 25.03 | 8.54 | 8.38 | 10.15 | 15.82 | |||||
| ROCE (%) | 24.67 | 13.84 | 11.27 | 11.43 | 16.11 | |||||
| Asset Turnover Ratio | 2.59 | 2.64 | 2.32 | 2.09 | 2.46 | |||||
| PAT to CFO Conversion(x) | 2.88 | 1.4 | 2.11 | 4.74 | -0.78 | Working Capital Days | ||||
| Receivable Days | 66 | 70 | 75 | 73 | 65 | |||||
| Inventory Days | 51 | 44 | 52 | 62 | 46 | |||||
| Payable Days | 124 | 98 | 93 | 91 | 75 | |||||
The company was originally incorporated on March 17, 2005 as “Aristo Bio-Tech and Lifescience Private Limited” under the provisions of the Companies Act, 1956 with the Registrar of Companies, Maharashtra, Mumbai. Subsequently The company was converted into Public Limited Company and name of company was changed from “Aristo Bio-Tech and Lifescience Private Limited” to “Aristo Bio-Tech and Lifescience Limited” vide fresh certificate of incorporation dated May 20, 2020 issued by the Registrar of Companies, Mumbai. Further the Company has changed the registered office from State of Maharashtra to Gujarat vide Certificate of Registration of Regional Director order for Change of State dated November 18, 2021 issued by Registrar of Companies, Ahmedabad.
The company is an agrochemical company engaged in the manufacturing, formulation, supplying, packaging and job work services in various Pesticides such as Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals for India as well as for Export. Agrochemical industries are very vast field and deals with production and distribution of pesticides and fertilizers to increase the crop yields. Agrochemicals (Crop protection products/pesticides) are designed to protect crops from insects, diseases and weeds. Currently the company has 182 products registered with CIB&RC for manufacturing and sales.
The company supplies its products to various states and its manufacturing agrochemicals such as Insecticides, Herbicides, Fungicides and Plant Growth Regulators which are directly sold to its customers and is also engaged in Job work as per customer requirements. The company is an ISO 9001: 2015 certified company for Quality Management System which confirms to the requirements of the quality standard for manufacturing of agrochemicals and pesticides and SMERA SME 3 for good credit worthiness.
The company’s diversified product portfolio can be classified as Herbicides/Weedicides, Fungicides, Plant Growth Regulator and Insecticides. Agrochemicals are an important agricultural support and boosts to it, while preventing, reducing and eliminating the impact of disease to increase food output and safety. The company has risen out the diversified portfolio of agrochemical product segment. Instituted with a vision to cater to growing needs of the agriculture market and provide high quality products, it now bags a wide range of agrochemicals products in its product portfolio like herbicides, insecticides, fungicides, plant growth regulators & fertilizers in various forms - liquid, dust, powder and granules. The company has expanded its operations beyond the borders of its state of inception to Punjab and Uttar Pradesh.
Business area of the company
The company is a dedicated Crop Protection company providing Best Quality manufacturing, formulation, supply and packaging job work services for various Pesticides : Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals in India as well as for Export.
Key Events and Milestones
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
